Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2007.001 | Self Management and the Role of Pharmacists in Developing An Effective Primary Care System: Developing A Consensus Based Policy Framework | YEOH Eng Kiong |
| 2003.164 | Amonafide: Individual Phenotype-Adjusted Chemotherapy for Women with Metastatic Breast Cancer Who have Progressed Despite Prior Chemotherapy | Prof. Yeo Winnie |
| 2003.030 | A Phase 2 Study of Irofulven as First Line Therapy in Recurrent or Metastatic Gastric Cancer | Prof. Yeo Winnie |
| 2006.263 | Detection of Circulating Tumor Cells in Patients with Breast Cancer | YEO Winnie |
| 2004.091 | A Phase III, Randomized Open Label Multicenter Study Comparing GW572016 and Capecitabine (Xeloda) Versus Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer | Prof. Yeo Winnie |
| 2002.433 | Hepatitis B Virus-Related Complications of Cytotoxic Chemotherapy in Patients with Inoperable Hepatocellular Carcinoma | Prof. Yeo Winnie |
| 2002.469 | A Randomized, Double-blind, Parallel-group Study Conducted Under In-house Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting Associated with Moderately Emetogenic Chemotherapy (Revised : CRE-2002.321-T) | Prof. Yeo Winnie |
| 2006.230 | An Open Label International Multi-Center Phase 2 Activity and Safety Study of SU011248 in Patients with Unresectable Hepatocellular Carcinoma | YEO Winnie |
| 2007.199 | An Open-Label, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced Hepatocellular Carcinoma (HCC) | Prof. Yeo Winnie |
| 2005.418 | A Randomized Double-Blind Phase-2 Study of Anastrozole Plus Lonafarnib (SCH 66336) or Anastrozole Plus Placebo for the Treatment of Subjects With Advanced Breast Cancer | Prof. Yeo Winnie |
| 2005.369 | Randomized Phase II Study of the Combination of Oral Vinorelbine With Capecitabine Versus A Sequential Regimen of Oral Vinorelbine and Capecitabine Versus the Combination of Docetaxel and Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines | Prof. Yeo Winnie |
| 2002.111 | Phase II Study of Gemcitabine/Carboplatin Combination Chemotherapy As First Line Therapy Or Recurrent Or Metastatis Breast Cancer | Prof. Yeo Winnie |
| 2004.421 | A Phase III Randomized, Double-Blind Study to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Adriamycin-Cyclophosphamide Adjuvant Chemotherapy in Chinese Breast Cancer Patients | Prof. Yeo Winnie |
| 2001.238 | Randomised Double-blind Trial in Postmenopausal Women with Primary Breast Cancer Who Have Received Adjuvant Tamoxifen for 2-3 years, Comparing Subsequent Adjuvant Exemestane Treatment with Further Tamoxifen | Prof. Yeo Winnie |
| 2005.020 | A Phase II Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled, Dose-Ranging, Parallel Group Study of the Safety and Efficacy of The Oral Neurokinin-1 Receptor Antagonist, GW679769 When Administered as a Daily Doses of 50mg, 100mg and 150mg Oral Tablets in Combination with Ondansetron Hydrochloride and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Subjects Receiving Highly Emetogenic Cisplatin-based Chemotherapy | Prof. Yeo Winnie |
| 2006.280 | A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2 Overexpressing Breast Cancer | Prof. Yeo Winnie |
| 2006.304 | A Phase III, Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group Study of the Safety and Efficacy of the Intravenous and Oral Formulations of the Neurkinin-1 Receptor Antagonist, Casopitant (GW679769) in Combination with Ondansetron and Dexamethasone for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy | Prof. Yeo Winnie |
| 2006.205 | An Open Label International Multi-Center Phase 2 Activity and Safety Study of SU011248 in Patients with Advanced / Metastatic Gastric Cancer Progressing or Recurring After One Prior Chemotherapy | Prof. Yeo Winnie |
| 2002.394 | An Open-Label Phase IIa Trial of Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients with Advanced Local or Metastatic Gastric Cancer | Prof. Yeo Winnie |
| 2002.062 | Randomized Double Blind Trial of Megestrol Acetate Versus Placebo for the Treatment of Inoperable Hepatocellular Carcinoma: An Asia-Pacific Hepatocellular Carcinoma Trials Group | Prof. Yeo Winnie |
| 2005.463 | Novel Therapeutics Using Inhibitor of histone Deacetylation - PXD101 - by Targeting Epigenetic Biomarkers for Hepatocellular Carcinoma | YEO Winnie |
| 2006.414 | A Randomized, Double-Blind, Parallel Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Moderately Emetogenic Chemotherapy | Prof. Yeo Winnie |
| 2005.197 | An Open-Label Multicenter Randomized Phase 3 Study Comparing the Combination of DOXIL_/CAELYX_ and YONDELIS | Prof. Yeo Winnie |
| 2006.355 | A Randomized 2-Arm, Open-Label, Phase II Study of BMS-582664, Administered Orally at A Dose of 800mg Daily or Doxorubicin Administered Intravenously At A Dose of 60 mg/m2 Every 3 Weeks In Patients with Unresectable, Locally Advanced or Metastatic Hepatocellular Carcinoma | Prof. Yeo Winnie |
| 2006.226 | A Randomized, Double Blind, Placebo-Controlled, Multicenter, Phase III Study Comparing the Activity of Paclitaxel Plus Trastuzumab Plus Lapatinib to Paclitaxel Plus Trastuzumab Plus Placebo in Women with ErbB2 Overexpressing Metastatic Breast Cancer | Prof. Yeo Winnie |
| 2001.415 | A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination with Doxorubicin and Cyclophosphamide (TAC) Versus Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC_T) as Adjuvant Treatment of Operable Breast Cancer Her2neu Negative Patients with Positive Axillary Lymph Nodes | Prof. Yeo Winnie |
| 2007.247 | An Open-Label Multicenter Study Administering Lapatinib and Capecitabine (Xeloda) in Women with Advanced or Metastatic Breast Cancer | Prof. Yeo Winnie |
| 2005.288 | A Phase I/II Study of PXD101 in Patients with Unresectable Hepatocellular Carcinoma With Pharmacokinetic and Pharmacodynamic Evaluation | Prof. Yeo Winnie |
| 2004.143 | The Role of Drug Resistance Genes in Chemotherapy Resistance in Patients with Inoperable Hepatocellular Carcinoma - Analysis of Cytogenetic, Genetic and Clinical Factors | YEO Winnie |
| 2005.002 | The Effectiveness of Psychosocial Intervention with Eastern Body-Mind-Spirit Approach in Enhancing the Quality of Life of Breast Cancer Patients | YEO Winnie |
| 2004.420 | The Association of Pharmacogenetics and Chemotherapy-Induced Toxicities in Breast Cancer Patients Receiving Chemotherapy | YEO Winnie |
| 2005.127 | Detection of Tumour Suppressor Gene DLC1 in Hepatocellular Carcinoma | YEO Winnie |
| 2006.148 | Quality of Life of Nasopharyngeal Cancer (NPC) Patients at Diagnosis and 5+ years after Radical Radiotherapy; A Hong Kong Experience Using SF-36v2 and Norm-based Scoring Algorithm | YAU Sau Han |
| 2005.417 | Effectiveness of Soft Versus Rigid Splinting Designs for First Carpometacarpal Joint Arthritis | YAU Carmen |
| 2010.122 | Detection of Patent Foramen Ovale in Young Patients with Stroke by Transthoracic Saline Contrast Echocardiography in Hong Kong | Yat Yin LAM |
| 2009.082 | Prevalence of depressive disorder among Chinese chronic pain patients in Hong Kong | YAP Jacqueline |
| 2004.313 | To Test the Reliability of Richmond Agitation Sedation Score (RASS score) in an Adult ICU | YAP Hui Yi Florence |
| 2007.507 | Studies on a New Therapeutic Strategy to Enhance mRNA / Protein Expression of Endothelial Nitric Oxide Synthase (eNOS) and NO-related Function in Disease - Use of eNOS Enhancer | YANG Qin |
| 2005.262 | Intervention of Drooling in Children with Neurological Disability | YANG Li Chien Hellen (No email contact) |
| 2012.131 | Psychiatric Morbidity in Adult Patients with Cervical Dysplasia in a Colposcopy Clinica in Hong Kong | YAN Tin Yee Connie |
| 2011.234 | Predicting Outcomes in Acute Coronary Syndrome: A Translational Approach Integrating Population-Specfic Clinical Risk Models, Platelet Reactivity and Metabolomic Biomarkers | YAN Ping Yen Bryan |
| 2011.237 | Management and Prognosis of Patients with Minor Coronary Artery Disease | YAN Ping Yen Bryan |
| 2011.534 | Type D personality in patients contemplating coronary revascularization | YAN Ping Yen Bryan |
| 2007.175 | Identification of Adult Stem Cell Markers and their Roles in Maintenance of Plurioptency | YAN Hin Fai Gary |
| 2010.343 | Difficulties, satisfaction, and coping strategies of the family caregivers of stroke survivors | YAM Yim Ling |
| 2005.211 | Management of Drooling for Children with Neurological Problems in Hong Kong | YAM Ka Ling Winnie |
| 2002.505 | Reliability of the Modified Ashworth Scale and the Modified Tardieu Scale in the Assessment of Lower Limb in Children with Cerebral Palsy | YAM Ka Ling Winnie |
| 2003.335 | Reliability and Validity of the Chinese Health-related Quality of Life Measure for Youth with Epilepsy | YAM Ka Ling Winnie |
| 2005.094 | Subjective Quality of Life of Outpatients with Schizophrenia in Hong Kong and Beijing: The Role of Socio-demographic and Clinical Factors | XIANG Yutao |
| 2007.285 | Quality of Life in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Their Parents in Hong Kong, China | XIANG Yu Tao |
Page 211 of 254.